Vasiliki Pappa

The role of microRNAs in normal and malignant hematopoiesis

Diamantina Vasilatou, Sotirios G. Papageorgiou, Vasiliki Pappa et al. · European Journal Of Haematology · 2009 · 182 citations · Full text

Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period

A. J. Norton, J. Matthews, Vasiliki Pappa et al. · Annals of Oncology · 1995 · 177 citations · Full text

Lymphoid Neoplasia, Mantle Cell Lymphoma, 20-Year Period +6

Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study

Meletios Α. Dimopoulos, Vânia Hungria, Atanas Radinoff et al. · The Lancet Haematology · 2023 · 113 citations

Hematological Malignancy, Oncology, Metronomic Therapy +10

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases

John Dervenoulas, Panagiotis Tsirigotis, G. Bollas et al. · Annals of Hematology · 2000 · 63 citations

Prognostic Factors, Thrombosis, Treatment Outcome +5

Nodular type of lymphocyte predominant Hodgkin’s disease. A clinical study of 50 cases

Vasiliki Pappa, A. J. Norton, Rajnish K. Gupta et al. · Annals of Oncology · 1995 · 52 citations

Lymphoid Neoplasia, Autoimmune Disease, Immunodeficiencies +8